Search

Your search keyword '"Bonten, M"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Bonten, M" Remove constraint Author: "Bonten, M" Database Complementary Index Remove constraint Database: Complementary Index
64 results on '"Bonten, M"'

Search Results

1. Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.

2. Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17).

3. Faecal carriage, risk factors, acquisition and persistence of ESBL-producing Enterobacteriaceae in dogs and cats and co-carriage with humans belonging to the same household.

4. Seasonality in carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in the general population: a pooled analysis of nationwide cross-sectional studies.

5. Correction to: Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.

6. Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls.

7. Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.

8. ESBL carriage in pig slaughterhouse workers is associated with occupational exposure.

9. ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage.

10. Risk factors for the acquisition of OXA-48-producing Enterobacteriaceae in a hospital outbreak setting: a matched case-control study.

11. Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

12. Gram-positive cocci in Dutch ICUs with and without selective decontamination of the oropharyngeal and digestive tract: a retrospective database analysis.

14. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

15. Molecular epidemiology of MRSA in 13 ICUs from eight European countries.

16. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.

17. Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy.

18. Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11.

19. Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients.

20. Bacteraemic and non-bacteraemic/urinary antigen-positive pneumococcal community-acquired pneumonia compared.

23. Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands.

24. Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases.

25. Selective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: a cost-effectiveness analysis.

26. Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study.

27. Trends in primary-care consultations, comorbidities, and antibiotic prescriptions for respiratory infections in The Netherlands before implementation of pneumococcal vaccines for infants.

28. High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17.

30. Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial.

31. Cost-effectiveness of targeted screening for hepatitis C in The Netherlands.

32. Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing.

33. Not All Patients with Vancomycin-Resistant Enterococci Need To Be Isolated.

35. Relative Effects of Barrier Precautions and Topical Antibiotics on Nosocomial Bacterial Transmission: Results of Multi-compartment Models.

36. An algorithm to estimate the importance of bacterial acquisition routes in hospital settings.

37. Potential Confounding in Evaluating Infection-Control Interventions in Hospital Settings: Changing Antibiotic Prescription.

38. Controlling methicillin-resistant Staphylococcus aureus: Quantifying the effects of interventions and rapid diagnostic testing.

39. Genotyping and Preemptive Isolation to Control an Outbreak of Vancomycin-Resistant Enterococcus faecium.

40. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.

41. Unnoticed Spread of Integron-Carrying Enterobacteriaceae in Intensive Care Units.

42. Are Active Microbiological Surveillance and Subsequent Isolation Needed to Prevent the Spread of Methicillin-Resistant Staphylococcus aureus?

43. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients.

44. The development of ventilator-associated pneumonia does not change aspects of mechanical ventilation.

45. Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm).

46. Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit.

47. Value of phenotyping methods as an initial screening of Pseudomonas aeruginosa in epidemiologic studies.

48. Antibiotic resistance of Escherichia coli in fecal samples of healthy people in two different areas in an industrialized country.

49. Indications for antibiotic use in ICU patients: a one-year prospective surveillance.

50. High prevalence of antibiotic resistant Escherichia coli in faecal samples of students in the south-east of The Netherlands.

Catalog

Books, media, physical & digital resources